Usefulness of NTproBNP in the emergency management of patients with severe dyspnea and an uncertain heart failure diagnosis;Utilidad del NTproBNP en el manejo urgente del paciente con disnea severa y diagnóstico dudoso de insuficiencia cardíaca

Revista Espanola de Cardiologia

Volumn 58, Issue 10, 2005, Pages 1155-1161

  Pascual Figal, Domingo A ^a,b   Cerdán Sánchez, María C ^a   Noguera Velasco, José A ^a   Pina, Teresa Casas ^a   Gimeno, Luis Muñoz ^a   García Rodríguez, Rosa ^a   Ruipérez Abizanda, Juan A ^a   Martínez Hernández, Pedro ^a   Valdés Chávarri, Mariano ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

^b NONE   (Spain)

Author keywords

Diagnosis; Dyspnea; Heart failure; Natriuretic peptides; Prognosis

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE SEVERITY; DYSPNEA; FEMALE; FIRST AID; HEART FAILURE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATIENT MONITORING; PREDICTION; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; STATISTICAL SIGNIFICANCE;

EID: 28344434822     PISSN: 03008932     EISSN: None     Source Type: Journal    
DOI: 10.1157/13079909     Document Type: Article

References (33)

1. Mulrow C, Lucey C, Farnett L. Discriminating causes of dyspnoea through the clinical examination. J Gen Intern Med. 1993; 8:383-92.
2. Remes J, Miettinen H, Reunanen A, Pyorala K. Validity of clinical diagnoses of heart failure in a primary care setting. Eur Heart J. 1991;12:315-21.
3. Nakagawa O, Ogawa Y, Itoh H, Suga S, Komatsu Y, Kishimoto I, et al. Rapid transcriptional activation and early mRNA turnover of BNP in cardiocyte hypertrophy: evidence for BNP as an «emergency» cardiac hormone against ventricular overload. J Clin Invest. 1995; 96:1280-7.
4. Grantham JA, Borgeson DD, Burnett JC. BNP: patohysiological and potential therapeutic roles in acute congestive heart failure. Am J Physiol. 1997;92:1077-83.
5. Tsutamoto T, Wada A, Maeda K, Hisanaga T, Mabuchi N, Hayashi M, et al. Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction. Am Heart J. 1998;135:825-32.
6. Daggubati S, Parks JR, Overton RM, Cintron G, Schocken DD, Vesely DL. Adrenomedullin, endothelin, neuropeptide Y, atrial, brain, and C-natriuretic prohormone peptides compared as early heart failure indicators. Cardiovasc Res. 1997;36:246-55.
7. Wieczorek SJ, Wu AH, Christenson R, Krishnaswamy P, Gottlieb S, Rosano T, et al. A rapid B-Type natriuretic peptide assay accurately diagnoses ventricular dysfunction and heart failure: a multicenter evaluation. Am Heart J. 2002;144:834-9.
8. McDonagh TA, Robb SD, Murdoch DR, Morton JJ, Ford I, Morrison CE, et al. Biochemical detection of left-ventricular systolic dysfunction. Lancet. 1998;351:9-13.
9. Tsutamoto T, Wada A, Maeda K, Hisanaga T, Maeda Y, Fukai D, et al. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction. Circulation. 1997; 96:509-16.
10. Koglin J, Pehlivanli S, Schwaiblmair M, Vogeser M, Cremer P, Von Scheidt W. Role of brain natriuretic peptide in risk stratification of patients with congestive heart failure. J Am Coll Cardiol. 2001;38:1934-41.
11. Kirk V, Bay M, Parner J, Krogsgaard K, Herzog TM, Boesgaard S, et al. N-terminal proBNP and mortality in hospitalised patients with heart failure and preserved vs. reduced systolic function: data from the prospective CHHF study. Eur J Heart Fail. 2004; 6:335-41.
12. Davis M, Espiner E, Richards G, Billings J, Town I, Neill A, et al. Plasma brain natriuretic peptide in assessment of acute dyspnoea. Lancet. 1994;343:440-4.
13. Dao Q, Krishnaswamy P, Kazanegra R, Harrison A, Amirnovin R, Lenert L, et al. Usefulness of B-type natriuretic peptide in the diagnoses of congestive heart failure in an urgeNTcare setting. J Am Coll Cardiol. 2001;37:379-85.
14. McCullough PA, Nowak RM, McCord J, Hollander JE, Herrmann HC, Steg PG, et al. B-type natriuretic peptide and clinical judgment in emergency diagnoses of heart failure. Analysis from breathing not properly (BNP) multinational study. Circulation. 2002;106:416-22.
15. Maisel AS, Krishnaswamy P, Nowak RM, McCord J, Hollander JE, Duc P, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnoses of heart failure. N Engl J Med. 2002;347:161-7.
16. Mueller C, Scholer A, Laule-Kilian K, Martina B, Schindler C, Buser P, et al. Use of B-type natriuretic peptide in the evaluation and management of acute dyspnoea. N Engl J Med. 2004;350: 647-54.
17. Hunt PJ, Richards AM, Nicholls MG, Yandle TG, Doughty RN, Espiner EA. Inmunoreactive amino-terminal pro-brain natriuretic peptide (NTProBNP): a new marker of cardiac impairment. Clin Endocrinol. 1997;47:287-96.
18. Hall C. Essential biochemistry and physiology of (NTpro) BNP. Eur J Heart Fail. 2004;6:257-60.
19. Lainchbury JG, Campbell E, Frampton CM, Yandle TG, Nicholls MG, Richards AM, et al. Brain natriuretic peptide and N-terminal brain natriuretic peptide in the diagnoses of heart failure in patients with acute shortness of breath. J Am Coll Cardiol. 2003;42: 728-35.
20. Redfield MM, Rodeheffer RJ, Jacobsen SJ, Mahoney DW, Bailey KR, Burnett JC Jr. Plasma brain natriuretic peptide concentration: impact of age and gender. J Am Coll Cardiol. 2002;40:976-82.
21. The task force on heart failure of the European society of cardiology. Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J. 2001;22:1527-60.
22. Zweig MH, Campbell G. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem. 1993;39:561-77.
23. Hobbs FD, Davis RC, Roalfe AK, Hare R, Davies MK. Reliability of N-terminal pro-brain natriuretic peptide assay in diagnosis of heart failure: cohort study in representative and high risk community populations. BMJ. 2002;324:1-5.
24. Wright SP, Doughty RN, Pearl A, Gamble GD, Whalley GA, Walsh HJ, et al. Plasma amino-terminal pro-brain natriuretic peptide and accuracy of heart failure diagnosis in primary care. J Am Coll Cardiol. 2003;42:1793-800.
25. McDonagh TA, Holmer S, Raymond I, Luchner A, Hildebrant P, Dargie HJ. NTproBNP and the diagnosis of heart failure: a pooled analysis of three European epidemiological studies. Eur J Heart Fail. 2004;6:269-73.
26. Cosín J, Hernándiz A, Díez JL, Capdevilla C, Salvador A, Diago JL, et al. Valor del NTproBNP en población adulta extrahospitalaria. Rev Esp Cardiol. 2003;56:236-44.
27. Bayés-Genís A, Santalo-Bel M, Zapico-Muniz E, López L, Cotes C, Bellido J, et al. NTproBNP in the emergency diagnosis and in-hospital monitoring of patients with dyspnoea and ventricular dysfunction. Eur J Heart Fail. 2004;6:301-8.
28. Rame JE, Sheffield MA, Dries DL, Gardner EB, Toto KH, Yancy CW, et al. Outcomes after emergency department discharge with a primary diagnoses of heart failure. Am Heart J. 2001;142:714-9.
29. Harrison A, Morrison LK, Krishnaswamy P, Kazanegra R, Clopton P, Dao Q, et al. B-type natriuretic peptide predicts future cardiac events in patients presenting to the emergency department with dyspnoea. Ann Emerg Med. 2002;39:131-8.
30. Cheng V, Kazanagra R, García A, Lenert L, Krishnaswamy P, Gardetto N, et al. A rapid test for B-type peptide predicts treatment outcomes in patients admitted for descompensated heart failure: a pilot study. J Am Coll Cardiol. 2001;37:386-91.
31. Ten Wolde M, Tulevski II, Mulder JW, Sohne M, Boomsma F, Mulder BJ, et al. Brain natriuretic peptide as a predictor of adverse outcome in patients with pulmonary embolism. Circulation. 2003;107:2082-4.
32. Witthaut R, Busch C, Fraunberger P, Walli A, Seidel D, Pilz G, et al. Plasma atrial natriuretic peptide and brain natriuretic peptide are increased in septic shock: impact of interleukin-6 and sepsis-associated left ventricular dysfunction. Intensive Care Med. 2003; 29:1696-702.
33. Nagaya N, Nishikimi T, Okano Y, Uematsu M, Satoh T, Kyotani S, et al. Plasma brain natriuretic peptide levels increase in proportion to the extent of right ventricular dysfunction in pulmonary hypertension. J Am Coll Cardiol. 1998;31:202-8.